Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-04-23

FDA Approved: ZOLPIDEM TARTRATE — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's original ANDA for zolpidem tartrate, a generic sleep medication for short-term treatment of insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zolpidem Tartrate (zolpidem tartrate)

Snippet

ORIG AP for ZOLPIDEM TARTRATE (ZOLPIDEM TARTRATE)